Ingevity reports second quarter 2025 financial results
NGVTNORTH CHARLESTON, S.C.--(BUSINESS WIRE)--Ingevity Corporation (NYSE: NGVT) today reported its financial results for the second quarter 2025.
August 4, 2025Earnings
Read more →Ingevity Expands Capa Caprolactone Distribution Network By Establishing Jamplast As Exclusive Distributor For Capa TP For Bioplastics In US And Canada
NGVTJune 6, 2025
Read more →Wells Fargo Maintains Equal-Weight on Ingevity, Raises Price Target to $38
NGVTMay 7, 2025
Read more →Ingevity Widens FY2025 Sales Guidance from $1.30B-$1.40B to $1.25B-$1.40B vs $1.36B Est
NGVTMay 5, 2025
Read more →Ingevity Q1 Adj. EPS $0.99 Beats $0.74 Estimate, Sales $284.00M Miss $285.47M Estimate
NGVTMay 5, 2025
Read more →Wells Fargo Maintains Equal-Weight on Ingevity, Lowers Price Target to $32
NGVTApril 9, 2025
Read more →BMO Capital Upgrades Ingevity to Outperform, Raises Price Target to $65
NGVTFebruary 26, 2025
Read more →Ingevity Says Business Portfolio Review Is Progressing With Recently Announced Strategic Alternatives
NGVTFebruary 25, 2025
Read more →BMO Capital Maintains Market Perform on Ingevity, Raises Price Target to $62
NGVTFebruary 20, 2025
Read more →Ingevity Expects FY25 Sales Of $1.3B - $1.4B, Est $1.448B
NGVTFebruary 18, 2025
Read more →Ingevity Q4 2024 Adj EPS $0.95 Beats $0.31 Estimate, Sales $298.80M Miss $310.80M Estimate
NGVTFebruary 18, 2025
Read more →In-Depth Examination Of 4 Analyst Recommendations For Ingevity
NGVTOctober 31, 2024
Read more →BMO Capital Maintains Market Perform on Ingevity, Raises Price Target to $47
NGVTOctober 31, 2024
Read more →Ingevity: Q1 Earnings Insights
NGVTIngevity (NYSE:NGVT) reported its Q1 earnings results on Wednesday, May 4, 2022 at 05:15 PM. Here's what investors need to know about the announcement. Earnings Ingevity beat estimated earnings by 55.77%, reporting an EPS of $1.62 versus an estimate of $1.04.
May 4, 2022
Read more →Ingevity Raises Top Ends Of FY22 Sales, Adj. EBITDA Guidance; Sees FY22 Sales $1.525B-$1.65B Vs $1.54B Est., Adj. EBITDA $430M-$470M
NGVTMay 4, 2022
Read more →Ingevity Q1 Adj. EPS $1.62 Beats $1.04 Estimate, Sales $382.80M Beat $341.58M Estimate
NGVTMay 4, 2022
Read more →